JP2021513861A5 - - Google Patents

Info

Publication number
JP2021513861A5
JP2021513861A5 JP2020544270A JP2020544270A JP2021513861A5 JP 2021513861 A5 JP2021513861 A5 JP 2021513861A5 JP 2020544270 A JP2020544270 A JP 2020544270A JP 2020544270 A JP2020544270 A JP 2020544270A JP 2021513861 A5 JP2021513861 A5 JP 2021513861A5
Authority
JP
Japan
Prior art keywords
aso
camk2d
seq
nucleotides
lna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020544270A
Other languages
English (en)
Japanese (ja)
Other versions
JP7500426B2 (ja
JP2021513861A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/018947 external-priority patent/WO2019165067A1/en
Publication of JP2021513861A publication Critical patent/JP2021513861A/ja
Publication of JP2021513861A5 publication Critical patent/JP2021513861A5/ja
Application granted granted Critical
Publication of JP7500426B2 publication Critical patent/JP7500426B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020544270A 2018-02-21 2019-02-21 Camk2dアンチセンスオリゴヌクレオチドおよびその使用 Active JP7500426B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201862633502P 2018-02-21 2018-02-21
US62/633,502 2018-02-21
US201862635954P 2018-02-27 2018-02-27
US62/635,954 2018-02-27
US201862665998P 2018-05-02 2018-05-02
US62/665,998 2018-05-02
US201862778679P 2018-12-12 2018-12-12
US62/778,679 2018-12-12
PCT/US2019/018947 WO2019165067A1 (en) 2018-02-21 2019-02-21 Camk2d antisense oligonucleotides and uses thereof

Publications (3)

Publication Number Publication Date
JP2021513861A JP2021513861A (ja) 2021-06-03
JP2021513861A5 true JP2021513861A5 (cg-RX-API-DMAC7.html) 2022-03-01
JP7500426B2 JP7500426B2 (ja) 2024-06-17

Family

ID=65729436

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020544270A Active JP7500426B2 (ja) 2018-02-21 2019-02-21 Camk2dアンチセンスオリゴヌクレオチドおよびその使用

Country Status (12)

Country Link
US (2) US11083444B2 (cg-RX-API-DMAC7.html)
EP (1) EP3755800A1 (cg-RX-API-DMAC7.html)
JP (1) JP7500426B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200140805A (cg-RX-API-DMAC7.html)
CN (1) CN112020559A (cg-RX-API-DMAC7.html)
AU (1) AU2019226001B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020016347A2 (cg-RX-API-DMAC7.html)
CA (1) CA3091789A1 (cg-RX-API-DMAC7.html)
IL (2) IL276549B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020008581A (cg-RX-API-DMAC7.html)
SG (1) SG11202007652UA (cg-RX-API-DMAC7.html)
WO (1) WO2019165067A1 (cg-RX-API-DMAC7.html)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE524121T1 (de) 2004-11-24 2011-09-15 Abdou Samy Vorrichtungen zur platzierung eines orthopädischen intervertebralen implantats
US8764806B2 (en) 2009-12-07 2014-07-01 Samy Abdou Devices and methods for minimally invasive spinal stabilization and instrumentation
US11998184B2 (en) * 2010-03-11 2024-06-04 Globus Medical, Inc Tissue retractor and methods of use
US8845728B1 (en) 2011-09-23 2014-09-30 Samy Abdou Spinal fixation devices and methods of use
US20130226240A1 (en) 2012-02-22 2013-08-29 Samy Abdou Spinous process fixation devices and methods of use
US9198767B2 (en) 2012-08-28 2015-12-01 Samy Abdou Devices and methods for spinal stabilization and instrumentation
US9320617B2 (en) 2012-10-22 2016-04-26 Cogent Spine, LLC Devices and methods for spinal stabilization and instrumentation
US10857003B1 (en) 2015-10-14 2020-12-08 Samy Abdou Devices and methods for vertebral stabilization
US10898175B2 (en) 2016-10-04 2021-01-26 Jgmg Bengochea, Llc Retractor extension clip systems
US10973648B1 (en) 2016-10-25 2021-04-13 Samy Abdou Devices and methods for vertebral bone realignment
US10744000B1 (en) 2016-10-25 2020-08-18 Samy Abdou Devices and methods for vertebral bone realignment
WO2019165067A1 (en) 2018-02-21 2019-08-29 Bristol-Myers Squibb Company Camk2d antisense oligonucleotides and uses thereof
US11806250B2 (en) 2018-02-22 2023-11-07 Warsaw Orthopedic, Inc. Expandable spinal implant system and method of using same
US11179248B2 (en) 2018-10-02 2021-11-23 Samy Abdou Devices and methods for spinal implantation
KR20200071198A (ko) 2018-12-10 2020-06-19 네오이뮨텍, 인코퍼레이티드 Nrf2 발현 조절 기반 T 세포 항암면역치료법
US11602337B2 (en) 2019-04-24 2023-03-14 Nuvasive, Inc. Transmission assembly
JP7337964B2 (ja) 2019-06-18 2023-09-04 ニューヴェイジヴ,インコーポレイテッド 組織牽引システム
US11547395B2 (en) 2019-06-18 2023-01-10 Nuvasive, Inc. Tissue retraction system
CN110731803B (zh) * 2019-11-20 2021-05-25 吕振乾 一种心外科手术辅助器
US11944286B2 (en) * 2020-01-24 2024-04-02 Lsi Solutions, Inc. Surgical rib retractor
WO2021158810A1 (en) 2020-02-05 2021-08-12 Bristol-Myers Squibb Company Oligonucleotides for splice modulation of camk2d
US12096923B2 (en) * 2020-07-10 2024-09-24 Warsaw Orthopedic, Inc. Tissue retractor, retraction modules, and associated methods
US12383249B2 (en) * 2020-07-10 2025-08-12 Warsaw Orthopedic, Inc. Tissue retractor, retraction modules, and associated methods
US11224415B1 (en) * 2020-07-10 2022-01-18 Warsaw Orthopedic, Inc. Tissue retractor
US12349889B2 (en) * 2020-07-10 2025-07-08 Warsaw Orthopedic, Inc. Tissue retractor, retraction modules, and associated methods
US11285014B1 (en) 2020-11-05 2022-03-29 Warsaw Orthopedic, Inc. Expandable inter-body device, system, and method
US12239544B2 (en) 2020-11-05 2025-03-04 Warsaw Orthopedic, Inc. Rhomboid shaped implants
US11291554B1 (en) 2021-05-03 2022-04-05 Medtronic, Inc. Unibody dual expanding interbody implant
US11395743B1 (en) 2021-05-04 2022-07-26 Warsaw Orthopedic, Inc. Externally driven expandable interbody and related methods
US12171439B2 (en) 2020-11-05 2024-12-24 Warsaw Orthopedic, Inc. Protected drill
US11963881B2 (en) 2020-11-05 2024-04-23 Warsaw Orthopedic, Inc. Expandable inter-body device, system, and method
US11638653B2 (en) 2020-11-05 2023-05-02 Warsaw Orthopedic, Inc. Surgery instruments with a movable handle
US11517363B2 (en) 2020-11-05 2022-12-06 Warsaw Orthopedic, Inc. Screw driver and complimentary screws
US12318308B2 (en) 2020-11-05 2025-06-03 Warsaw Orthopedic, Inc. Dual expandable inter-body device
US12121453B2 (en) 2020-11-05 2024-10-22 Warsaw Orthopedic, Inc. Dual wedge expandable implant with eyelets, system, and method of use
US11833059B2 (en) 2020-11-05 2023-12-05 Warsaw Orthopedic, Inc. Expandable inter-body device, expandable plate system, and associated methods
US11517443B2 (en) 2020-11-05 2022-12-06 Warsaw Orthopedic, Inc. Dual wedge expandable implant, system and method of use
US11376134B1 (en) 2020-11-05 2022-07-05 Warsaw Orthopedic, Inc. Dual expanding spinal implant, system, and method of use
KR20240028362A (ko) 2021-05-28 2024-03-05 라이엘 이뮤노파마, 인크. Nr4a3-결핍 면역 세포 및 이의 용도
KR20240027676A (ko) 2021-06-02 2024-03-04 라이엘 이뮤노파마, 인크. Nr4a3-결핍 면역 세포 및 이의 용도
US12268614B2 (en) 2021-06-24 2025-04-08 Warsaw Orthopedic, Inc. Interbody implant with adjusting shims
US11612499B2 (en) 2021-06-24 2023-03-28 Warsaw Orthopedic, Inc. Expandable interbody implant
US12440349B2 (en) 2021-11-01 2025-10-14 Warsaw Orthopedic, Inc. Expandable interbody implant and breakoff screw
US12414863B2 (en) 2021-06-24 2025-09-16 Warsaw Orthopedic, Inc. Expandable interbody implant and corresponding surgical tool
US12485019B2 (en) 2021-06-24 2025-12-02 Warsaw Orthopedic, Inc. Parallel jaw inserter
US12295865B2 (en) 2021-06-24 2025-05-13 Warsaw Orthopedic, Inc. Expandable interbody implant and corresponding inserter
US11730608B2 (en) 2021-07-13 2023-08-22 Warsaw Orthopedic, Inc. Monoblock expandable interbody implant
CN118119702A (zh) 2021-10-14 2024-05-31 隆萨销售股份有限公司 用于细胞外囊泡产生的经修饰的生产者细胞
US11850163B2 (en) 2022-02-01 2023-12-26 Warsaw Orthopedic, Inc. Interbody implant with adjusting shims
US20260083846A1 (en) 2022-05-19 2026-03-26 Lyell Immunopharma, Inc. Polynucleotides targeting nr4a3 and uses thereof
US12635998B2 (en) 2022-08-30 2026-05-26 Warsaw Orthopedic, Inc. Tissue retractor having operative corridor formed by dilator and blades
WO2024064952A1 (en) 2022-09-23 2024-03-28 Lyell Immunopharma, Inc. Methods for culturing nr4a-deficient cells overexpressing c-jun
WO2024077174A1 (en) 2022-10-05 2024-04-11 Lyell Immunopharma, Inc. Methods for culturing nr4a-deficient cells
CN118853661A (zh) * 2023-04-28 2024-10-29 时夕(广州)生物科技有限公司 编辑rna的方法、组合物及其应用
US12533241B2 (en) 2023-05-16 2026-01-27 Warsaw Orthopedic, Inc. Distracting and angling expandable interbody device
WO2025217398A1 (en) 2024-04-10 2025-10-16 Lyell Immunopharma, Inc. Methods for culturing cells with improved culture medium

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3749088A (en) 1971-06-23 1973-07-31 W Kohlmann Surgical retractor device
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
JP2823959B2 (ja) 1991-10-24 1998-11-11 アイシス・ファーマシューティカルス・インコーポレーテッド 改良された取り込みおよびその他の性質を持つ誘導化オリゴヌクレオチド
IL129507A0 (en) 1996-11-13 2000-02-29 Qbi Entpr Ltd Gene identification method
JP3756313B2 (ja) 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
EP1015469B2 (en) 1997-09-12 2015-11-18 Exiqon A/S Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
US6139493A (en) * 1998-07-08 2000-10-31 Koros; Tibor B. Retractor with adjustable length blades and light pipe guides
BRPI0008131B8 (pt) 1999-02-12 2021-05-25 Daiichi Sankyo Co Ltd composto ou um sal deste, análogo de oligonucleotídeo, composição farmacêutica, sonda para um gene,iniciador para começar a amplificação, uso de um análogo de oligonucleotídeo ou de um sal deste farmacologicamente aceitável, agente antisentido, e, agente antígeno
ATE356824T1 (de) 1999-05-04 2007-04-15 Santaris Pharma As L-ribo-lna analoge
US6617442B1 (en) 1999-09-30 2003-09-09 Isis Pharmaceuticals, Inc. Human Rnase H1 and oligonucleotide compositions thereof
GB2375172A (en) 2000-02-07 2002-11-06 Quark Biotech Inc Fas pathway genes
JP2005506098A (ja) * 2001-01-29 2005-03-03 デピュイ スパイン、インコーポレイテッド 脊髄椎弓根スクリュー配置用開創器及びその方法
AU2002324700A1 (en) 2001-08-14 2003-03-03 Bayer Ag Nucleic acid and amino acid sequences involved in pain
WO2005060667A2 (en) 2003-12-19 2005-07-07 The General Hospital Corporation Nucleic acid and amino acid sequences involved in pain
EP1470247A2 (en) 2001-11-05 2004-10-27 Deutsches Krebsforschungszentrum Novel genetic markers for leukemias
US20030157082A1 (en) 2002-01-31 2003-08-21 Millennium Pharmaceuticals, Inc. Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480,20893, 33230,1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules
US20040101855A1 (en) * 2002-11-22 2004-05-27 Isis Pharmaceuticals Inc. Modulation of PPAR binding protein expression
US9259144B2 (en) 2002-07-11 2016-02-16 Nuvasive, Inc. Surgical access system and related methods
AU2003255337A1 (en) 2002-07-31 2004-02-23 Kylix B.V. Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
JP2006513701A (ja) 2002-10-11 2006-04-27 アーラム バイオシステムズ インコーポレイテッド 核酸ベースのシグナルトランスデューサーを含む立体構造的に敏感なプローブを有する標的検出システム
US7850608B2 (en) 2002-10-25 2010-12-14 K2M, Inc. Minimal incision maximal access MIS spine instrumentation and method
EP2284269B1 (en) * 2002-11-18 2017-08-09 Roche Innovation Center Copenhagen A/S Antisense design
US7691057B2 (en) 2003-01-16 2010-04-06 Nuvasive, Inc. Surgical access system and related methods
US7256200B2 (en) 2003-02-10 2007-08-14 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Method and composition for potentiating an oplate analgesic
US7819801B2 (en) 2003-02-27 2010-10-26 Nuvasive, Inc. Surgical access system and related methods
US20050085436A1 (en) 2003-07-08 2005-04-21 Hao Li Method to treat conditions associated with insulin signalling dysregulation
US7481766B2 (en) 2003-08-14 2009-01-27 Synthes (U.S.A.) Multiple-blade retractor
US20050137461A1 (en) * 2003-12-18 2005-06-23 Depuy Spine, Inc. Telescoping blade assembly and instruments for adjusting an adjustable blade
US7374927B2 (en) * 2004-05-03 2008-05-20 Affymetrix, Inc. Methods of analysis of degraded nucleic acid samples
WO2006042241A2 (en) 2004-10-08 2006-04-20 Nuvasive, Inc. Surgical access system and related methods
JP2006223228A (ja) 2005-02-18 2006-08-31 Dainippon Sumitomo Pharma Co Ltd 自己免疫疾患治療剤のスクリーニング方法
US20060287584A1 (en) * 2005-06-16 2006-12-21 Javier Garcia-Bengochia Surgical retractor extensions
CN1904900A (zh) * 2005-07-28 2007-01-31 中国科学院生物物理研究所 人类的内源性siRNA序列及其应用和筛选方法
WO2007031091A2 (en) 2005-09-15 2007-03-22 Santaris Pharma A/S Rna antagonist compounds for the modulation of p21 ras expression
EP1962888A2 (en) 2005-11-18 2008-09-03 Myogen, Inc. Uses for camkii and hdacs in the treatment of heart conditions
DE602007009487D1 (de) 2006-01-27 2010-11-11 Isis Pharmaceutical Inc 6-modifizierte bicyclische nukleinsäureanaloga
US20090156540A1 (en) * 2006-03-07 2009-06-18 Mckenna Katherine Method for diagnosing and/or predicting the development of an allergic disorder and agents for treating and/or preventing same
EP2505646A1 (en) 2006-05-05 2012-10-03 Isis Pharmaceuticals, Inc. Compounds and methods for modulating expression of CRP
CA2651453C (en) 2006-05-11 2014-10-14 Isis Pharmaceuticals, Inc. 5'-modified bicyclic nucleic acid analogs
US7666854B2 (en) 2006-05-11 2010-02-23 Isis Pharmaceuticals, Inc. Bis-modified bicyclic nucleic acid analogs
WO2008020435A2 (en) 2006-08-15 2008-02-21 Quark Pharmaceuticals, Inc Compositions and methods for treatment of mood disorders
ES2534430T3 (es) 2006-08-28 2015-04-22 The University Of Western Australia Método de modulación de la expresión del receptor del factor de crecimiento epidérmico (EGFR) que implica miARN
GB0617222D0 (en) 2006-08-31 2006-10-11 Vereniging Het Nl Kanker I Antibiotics
US8062217B2 (en) * 2007-01-26 2011-11-22 Theken Spine, Llc Surgical retractor with removable blades and method of use
US8580756B2 (en) 2007-03-22 2013-11-12 Santaris Pharma A/S Short oligomer antagonist compounds for the modulation of target mRNA
DK2170917T3 (da) 2007-05-30 2012-10-08 Isis Pharmaceuticals Inc N-Substituerede bicycliske nukleinsyreanaloge med aminomethylenbro
WO2008154401A2 (en) 2007-06-08 2008-12-18 Isis Pharmaceuticals, Inc. Carbocyclic bicyclic nucleic acid analogs
US20100273854A1 (en) * 2007-06-15 2010-10-28 Hagar Kalinski Compositions and methods for inhibiting nadph oxidase expression
AU2008272918B2 (en) 2007-07-05 2012-09-13 Isis Pharmaceuticals, Inc. 6-disubstituted bicyclic nucleic acid analogs
DE202007012284U1 (de) 2007-09-01 2007-10-25 Aesculap Ag & Co. Kg Chirurgischer Retraktor
WO2009067647A1 (en) 2007-11-21 2009-05-28 Isis Pharmaceuticals, Inc. Carbocyclic alpha-l-bicyclic nucleic acid analogs
US8841423B2 (en) 2008-04-28 2014-09-23 University Of Iowa Research Foundation Monoclonal antibodies specific for oxidized calcium/calmodulin dependent protein kinase II
WO2010036698A1 (en) 2008-09-24 2010-04-01 Isis Pharmaceuticals, Inc. Substituted alpha-l-bicyclic nucleosides
EP2177615A1 (en) 2008-10-10 2010-04-21 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Method for a genome wide identification of expression regulatory sequences and use of genes and molecules derived thereof for the diagnosis and therapy of metabolic and/or tumorous diseases
US8226554B2 (en) 2008-10-30 2012-07-24 Warsaw Orthopedic, Inc. Retractor assemblies for surgery in a patient
WO2010120969A1 (en) 2009-04-15 2010-10-21 Board Of Regents, The University Of Texas System Targeting of the mir-30 family and let-7 family as a treatment for heart disease
WO2010142805A1 (en) * 2009-06-12 2010-12-16 Santaris Pharma A/S New potent anti apob antisense compounds
US8563528B2 (en) * 2009-07-21 2013-10-22 Santaris Pharma A/S Antisense oligomers targeting PCSK9
EP2462153B1 (en) 2009-08-06 2015-07-29 Isis Pharmaceuticals, Inc. Bicyclic cyclohexose nucleic acid analogs
US9364495B2 (en) 2009-10-20 2016-06-14 Roche Innovation Center Copenhagen A/S Oral delivery of therapeutically effective LNA oligonucleotides
US9737288B2 (en) * 2010-03-11 2017-08-22 Globus Medical, Inc Tissue retractor and methods of use
US8846637B2 (en) 2010-06-08 2014-09-30 Isis Pharmaceuticals, Inc. Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
US20130253035A1 (en) 2010-08-16 2013-09-26 Duke University Camkk-beta as a target for treating cancer
EP2742138B1 (en) 2011-08-09 2020-06-24 Fred Hutchinson Cancer Research Center Methods and compositions for inhibiting the growth and/or proliferation of myc-driven tumor cells
US10023861B2 (en) 2011-08-29 2018-07-17 Ionis Pharmaceuticals, Inc. Oligomer-conjugate complexes and their use
EP2751567B1 (en) * 2011-09-01 2019-05-08 University of Iowa Research Foundation Oligonucleotide-based probes for detection of bacterial nucleases
JP2014531425A (ja) 2011-09-02 2014-11-27 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク 肥満の代謝異常を治療するためのCaMKII、IP3R、カルシニューリン、p38、およびMK2/3阻害剤
EP2753631A1 (en) 2011-09-07 2014-07-16 Marina Biotech, Inc. Synthesis and uses of nucleic acid compounds with conformationally restricted monomers
WO2013151999A1 (en) 2012-04-02 2013-10-10 President And Fellows Of Harvard College Cancer treatment and immune system regulation through fat10 pathway inhibition
EP2850092B1 (en) 2012-04-09 2017-03-01 Ionis Pharmaceuticals, Inc. Tricyclic nucleic acid analogs
WO2013173637A1 (en) * 2012-05-16 2013-11-21 Rana Therapeutics, Inc. Compositions and methods for modulating gene expression
CA2889044A1 (en) 2012-11-15 2014-05-22 Roche Innovation Center Copenhagen A/S Anti apob antisense conjugate compounds
WO2014077693A1 (en) * 2012-11-16 2014-05-22 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Means and methods for reducing an effect of aging in a mammalian cell
CN105517549B (zh) 2013-03-06 2018-11-23 阿略斯泰罗斯医疗公司 CaMKII抑制剂和其用途
US20140329755A1 (en) 2013-05-01 2014-11-06 Gilead Sciences, Inc. Combination therapy for the treatment of arrhythmias or heart failure
PL2992098T3 (pl) 2013-05-01 2019-09-30 Ionis Pharmaceuticals, Inc. Kompozycje i sposoby modulowania ekspresji hbv i ttr
MX367083B (es) * 2013-06-27 2019-08-05 Roche Innovation Ct Copenhagen As Oligomeros antisentido y conjugados con diana en la proteina-convertasa subtilisina/kexina tipo 9(pcsk9).
CA2960101C (en) 2014-09-05 2024-05-21 Allosteros Therapeutics, Inc. Substituted carboline derivative and compositions thereof useful as camkii inhibitors
WO2016126747A1 (en) 2015-02-02 2016-08-11 Meiragtx Uk Limited Regulation of gene expression by aptamer-mediated modulation of alternative splicing
EP3286318A2 (en) 2015-04-22 2018-02-28 Mina Therapeutics Limited Sarna compositions and methods of use
US10494632B2 (en) * 2015-07-10 2019-12-03 Alnylam Pharmaceuticals, Inc. Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof
EP3353305A4 (en) 2015-09-25 2019-09-18 Ionis Pharmaceuticals, Inc. Conjugated antisense compounds and their use
EP3353306A4 (en) 2015-09-25 2019-06-05 Ionis Pharmaceuticals, Inc. Conjugated antisense compounds and their use
WO2017106283A1 (en) * 2015-12-14 2017-06-22 Cold Spring Harbor Laboratory Compositions and methods for treatment of liver diseases
EP3481857B1 (en) * 2016-07-06 2026-02-11 Vertex Pharmaceuticals Incorporated Materials and methods for treatment of pain related disorders
EP3494229B1 (en) 2016-08-03 2023-10-25 Meiragtx UK II Limited High throughput cell-based screening for aptamers
WO2019049148A1 (en) 2017-09-10 2019-03-14 Carmel Haifa University Economic Corporation Ltd. METHOD OF TREATING DEPRESSION AND MAJOR DEPRESSIVE DISORDER
EP3740576A4 (en) 2018-01-18 2021-10-20 Advanced Regen Medical Technologies, LLC THERAPEUTIC COMPOSITIONS AND THEIR PREPARATION AND USE METHODS
WO2019165067A1 (en) 2018-02-21 2019-08-29 Bristol-Myers Squibb Company Camk2d antisense oligonucleotides and uses thereof
CA3098623A1 (en) 2018-05-07 2019-11-14 Alnylam Pharmaceuticals, Inc. Extrahepatic delivery

Similar Documents

Publication Publication Date Title
IL276549B1 (en) CAMK2D antisense oligonucleotides and their uses
JP6129844B2 (ja) 多量体オリゴヌクレオチド化合物
JP5898843B2 (ja) 血管新生、血管形成、若しくは血管修復を促進するか、又は腫瘍血管新生を阻害する方法
JP2014527819A5 (cg-RX-API-DMAC7.html)
JP2021510511A5 (cg-RX-API-DMAC7.html)
JP2013523164A5 (cg-RX-API-DMAC7.html)
CA2921457A1 (en) Heterochromatin forming non-coding rnas
WO2019076842A1 (en) NUCLEIC ACID MOLECULE FOR THE REDUCTION OF PAPD5 AND PAPD7 MRNA FOR THE TREATMENT OF HEPATITIS B INFECTION
CN102844434A (zh) Cetp表达的调节
WO2010120969A1 (en) Targeting of the mir-30 family and let-7 family as a treatment for heart disease
JP2014504857A (ja) ロックドヌクレオチドを含むmicroRNA阻害剤
JP2026002846A (ja) Angptl2アンチセンスオリゴヌクレオチドおよびその使用
WO2007137301A2 (en) Modulation of chrebp expression
JP2022524218A5 (cg-RX-API-DMAC7.html)
JP2025094072A (ja) B型肝炎ウイルス感染を処置するためのcops3阻害剤の使用
JP7499754B2 (ja) Microrna-134バイオマーカー
WO2022026648A1 (en) Inhibition of incexact1 to treat heart disease
AU2018421460B2 (en) Therapeutic uses and methods
JP2024026274A (ja) マイクロrna関連疾患の処置のための薬学的組成物
CN116438305A (zh) 用于治疗心力衰竭的miRNA的组合抑制
CN114829601A (zh) Sbds抑制剂用于治疗乙型肝炎病毒感染的用途
EP4185693B1 (en) Combinatorial inhibition of transcription factors for treatment of heart failure
KR20260016935A (ko) 안지오텐시노겐을 표적으로 하는 핵산 및 이의 용도
HK40116803A (en) Nucleic acid targeting angiotensinogen and use thereof
JP2006518999A (ja) チオレドキシン発現の改変のためのオリゴマー化合物